$XNCR SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more ® Designing Proteins Delivering Medicines Updated Results from Dose Expansion Cohorts in the Phase 1 Study of XmAb819 October 26, 2026
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	SCHEDULE 13G
29 Jul 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
08 Jul 2026	Form 4: Feigal Ellen, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Gorman Kevin Charles, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Gustafson Kurt A, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Klencke Barbara, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Montgomery Alan Bruce, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Ranieri Richard J, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Simpson Todd E, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
08 Jul 2026	Form 4: Deshaies Raymond Joseph, Director Received 10,302 shares as a grant or award · Granted 20,604 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Feigal Ellen, Director Sold 6,843 shares ($89.4K)
18 Jun 2026	144
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
17 Jun 2026	Form 4: Gorman Kevin Charles, Director Sold 7,527 shares ($92.7K)
17 Jun 2026	Form 4: Gustafson Kurt A, Director Sold 5,474 shares ($67.4K)
17 Jun 2026	Form 4: Ranieri Richard J, Director Sold 5,474 shares ($67.4K)
17 Jun 2026	Form 4: Montgomery Alan Bruce, Director Sold 5,064 shares ($62.3K)

Comments